Literature DB >> 21530315

Less invasive off-pump implantation of axial flow pumps in chronic ischemic heart failure: survival effects.

Ali Ghodsizad1, Bisjwit J Kar, Pranov Layolka, Abdullah Okur, Jose Gonzales, Christoph Bara, Matthias N Ungerer, Matthias Karck, Igor D Gregoric, Arjang Ruhparwar.   

Abstract

BACKGROUND: Off-pump implantation of left ventricular assist device (LVAD) axial or centrifugal flow pumps in patients with low ejection fraction (EF) is of major clinical relevance. In addition, all pre-clinical, long-term implantations performed so far have been carried out in healthy animals, but this does not reflect the eventual clinical setting. In this study we established a new technique using a miniaturized axial flow pump in sheep with chronically ischemic myocardium.
METHODS: Sheep (n = 15) underwent intracoronary sphere injection to create chronic ischemic heart failure. Reduced EF was assessed using transesophageal echocardiography. All animals underwent implantation of a new miniaturized axial flow pump via an extraperitoneal, subcostal surgical approach.
RESULTS: Our technique allows easy exposure of the diaphragmatic surface of the heart and the descending aorta. Ten animals (range 65 to 78 kg) underwent off-pump implantation 30 (range 25 to 33) days after intracoronary sphere injection. All animals had significantly reduced EF (25 ± 4.8%) and were receiving high doses of inotropic agents to maintain cardiac function. Nine animals survived the surgical procedure. The average 12-hour blood loss was 435 ml. Cardiac index improved significantly in all animals. The procedure time was not extended by any adverse events (60 to 145 minutes).
CONCLUSIONS: The extraperitoneal, subcostal surgical approach is less invasive than a median sternotomy and allows centrifugal or axial to be implanted quickly and without cardiopulmonary bypass (CPB). Avoiding CPB and an extensive mediastinal dissection can help to decrease significantly the number of complications in patients with end-stage organ failure.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530315     DOI: 10.1016/j.healun.2011.03.012

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

1.  Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure.

Authors:  Alexander Weymann; Bastian Schmack; Anton Sabashnikov; Christopher T Bowles; Philipp Raake; Rawa Arif; Markus Verch; Ursula Tochtermann; Jens Roggenbach; Aron Frederik Popov; Andre Ruediger Simon; Matthias Karck; Arjang Ruhparwar
Journal:  J Cardiothorac Surg       Date:  2014-03-29       Impact factor: 1.637

Review 2.  Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?

Authors:  Cheyenne C S Tseng; Faiz Z Ramjankhan; Nicolaas de Jonge; Steven A J Chamuleau
Journal:  Front Surg       Date:  2015-04-07

3.  COVID-19 infection in left ventricular assist device patients.

Authors:  Antonio Piperata; Tomaso Bottio; Gino Gerosa
Journal:  J Card Surg       Date:  2020-08-21       Impact factor: 1.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.